Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

KRAS mutational status of endoscopic biopsies matches resection specimens.

Journal of clinical pathology - 1 Jul 2012

Yang Qing-Hua, Schmidt Jason, Soucy Genvieve, Odze Robert, Dejesa-Jamanila Liza, Arnold Keely, Kuslich Christine, Lash Richard

Abstract excerpt

AIMS: This study was performed to determine systematically whether KRAS mutational analysis in biopsy tissue is a reliable indicator of KRAS status in subsequent corresponding resection specimens. METHODS: 30 colorectal cancer (CRC) patients with biopsy and corresponding subsequent surgical resection specimens were studied. KRAS mutational analysis was performed on each biopsy sample as well as two separate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biopsy
Share to Colon

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Rectum

Source

Identifiers

PMID: 22461648
DOI: 10.1136/jclinpath-2012-200746

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

KRAS mutational status of endoscopic biopsies matches resection specimens.PMID 22461648Read ↗

Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.Semantic proximity Read ↗

KRAS, NRAS, BRAF mutation comparison of endoscopic and surgically removed primary CRC paired samples: is endoscopy biopsy material adequate for molecular evaluation?Semantic proximity Read ↗

High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice.Semantic proximity Read ↗

KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients.Semantic proximity Read ↗

A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens.Semantic proximity Read ↗

Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspective.Semantic proximity Read ↗

KRAS mutations testing in colorectal carcinoma patients in Italy: from guidelines to external quality assessment.Semantic proximity Read ↗

Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review.Semantic proximity Read ↗

[Technical considerations for KRAS testing in colorectal cancer. The pathologist's point of view].Semantic proximity Read ↗

Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases.Semantic proximity Read ↗

KRAS and BRAF mutation analysis can be reliably performed on aspirated cytological specimens of metastatic colorectal carcinoma.Semantic proximity Read ↗

Challenges posed to pathologists in the detection of KRAS mutations in colorectal cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.